Gestational diabetes mellitus screening in pandemic times: Are there viable alternatives?
Aust N Z J Obstet Gynaecol
.
2020 Oct;60(5):E14-E15.
doi: 10.1111/ajo.13235.
Authors
Alexandre da Silva Rocha
1
,
Juliana Rombaldi Bernardi
2
3
,
Salete de Matos
1
,
Daniela Cortés Kretzer
1
,
Alice Carvalhal Schöffel
4
,
Felipe Moretti
5
6
,
José Antônio de Azevedo Magalhães
1
7
Affiliations
1
Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
2
Department of Nutrition, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
3
School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
4
Department of Social and Behavioral Health Sciences, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
5
Maternal-fetal Division (Head), Ottawa General Hospital, Ottawa, Canada.
6
School of Medicine, University of Ottawa, Ottawa, Canada.
7
Maternal-Fetal Division (Head), Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
PMID:
33043438
PMCID:
PMC7675496
DOI:
10.1111/ajo.13235
No abstract available
Publication types
Letter
MeSH terms
Diabetes, Gestational* / diagnosis
Diabetes, Gestational* / epidemiology
Female
Glucose Tolerance Test
Humans
Mass Screening
Pandemics
Pregnancy